References
- Bangham AD, Horne RW. (1964). Negative staining of phospholipids and their structural modification by surface active agents as observed in the electron microscope. J Mol Biol, 8, 660–668.
- Bolotin EM, Cohen R, Bar LK, Emanuel N, Ninio S, Barenholz Y, Lasic DD. (1994). Ammonium sulphate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandosomes. J Liposome Res, 4(1), 455–479.
- Chamberland S, Bayer AS, Schollaardt T, Wong SA, Bryan LE. (1989). Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrob Agents Chemother, 33(5), 624–634.
- Cheng J, Zhu JB, Wen N, Xiong F. (2006a). Stability and pharmacokinetic studies of o-palmitoylamylopectin anchored dipyridamole liposomes. Int J Pharm, 313(1–2), 136–143.
- Cheng J, Wen N, Xiong F, Chen SJ, Zhu JB. (2006b). Characterization, lung targeting profile and therapeutic efficiency of dipyridamole liposomes. J Drug Target, 14(10), 717–724.
- Chou TH, Chen SC, Chu IM. (2003). Effect of composition on the stability of liposomal irinotecan prepared by a pH gradient method. J Biosci Bioeng, 95(4), 405–408.
- Cullis PR, Hope MJ, Bally MB, Madden TD, Mayer LD, Fenske DB. (1997). Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim Biophys Acta, 1331(2), 187–211.
- Fauci AS. (2001). Infectious diseases: considerations for the 21st century. Clin Infect Dis, 32(5), 675–685.
- Fresta M, Spadaro A, Cerniglia G, Ropero IM, Puglisi G, Furneri PM. (1995). Intracellular accumulation of ofloxacin-loaded liposomes in human synovial fibroblasts. Antimicrob Agents Chemother, 39(6), 1372–1375.
- Furneri PM, Fresta M, Puglisi G, Tempera G. (2000). Ofloxacin-loaded liposomes: in vitro activity and drug accumulation in bacteria. Antimicrob Agents Chemother, 44(9), 2458–2464.
- Glavas-Dodov M, Fredro-Kumbaradzi E, Goracinova K, Simonoska M, Calis S, Trajkovic-Jolevska S, Hincal AA. (2005). The effects of lyophilization on the stability of liposomes containing 5-FU. Int J Pharm, 291(1–2), 79–86.
- Kellaway IW, Farr SJ. (1990). Liposomes as drug delivery systems to the lung. Adv Drug Deliv Rev, 5(1), 149–161.
- Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L. (2006). Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother, 50(9), 2946–2950.
- Puglisi G, Fresta M, Mazzone G, Furneri PM, Tempera G. (1995). Formulation parameters of fluoroquinolone-loaded liposomes and in vitro antimicrobial activity. Int J Pharmaceut, 118(1), 65–76.
- Robillard NJ, Scarpa AL. (1988). Genetic and physiological characterization of ciprlevofloxacin resistance in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother, 32(4), 535–539.
- Rodríguez-Hernández MJ, Saugar J, Docobo-Pérez F, de la Torre BG, Pachón-Ibáñez ME, García-Curiel A, Fernández-Cuenca F, Andreu D, Rivas L, Pachón J. (2006). Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii. J Antimicrob Chemother, 58(1), 95–100.
- Sun WT, Zhang N, Li AG, Zou WW, Xu WF. (2008a). Preparation and evaluation of N3-O-toluyl-fluorouracil-loaded liposomes. Int J Pharm, 353(1–2), 243–250.
- Sun WT, Zou WW, Huang GH, Li AG, Zhang N. (2008b). Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration. J Drug Target, 16(5), 357–365.
- Szoka F Jr, Papahadjopoulos D. (1978). Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA, 75(9), 4194–4198.
- Tewes F, Brillault J, Couet W, Olivier JC. (2008). Formulation of rifampicin–cyclodextrin complexes for lung nebulization. J Control Release, 129(2), 93–99.
- Vyas SP, Kannan ME, Jain S, Mishra V, Singh P. (2004). Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm, 269(1), 37–49.
- Wang JS, Zhu JB, Lv RQ, Shen W. (2005). Preparation of lung targeting azithromycin liposomes and its tissue distribution in mice. Acta Pharmaceutica Sinica, 40(3), 274–278.
- Wang SN, Deng YH, Zheng SH, Xu B, Li HQ, Bi DZ. (2003). Studies on preparation of ciprofloxacin liposomes and its tissue distribution in mice. Chin Pharm J, 38(4), 274–277.
- Zeng XM, Martin GP, Marriott C. (1995). The controlled delivery of drugs to the lung. Int J Pharm, 124(2), 149–164.